Pall launches GeneDisc Rapid Microbiology System for advanced microbial quality monitoring

Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today announced the introduction of the GeneDisc® Rapid Microbiology System for advanced microbial quality monitoring. This system represents Pall's latest quality assurance innovation for the pharmaceutical manufacturing industry.

“That can mean scrapped or reworked product, which represents considerable risk and cost. With the GeneDisc System, we can reliably eliminate those production risks in just a few hours”

"The GeneDisc Rapid Microbiology System represents a leap forward for applications of rapid microbiological analysis in the pharmaceutical manufacturing setting," says Ken Frank, President of Pall Life Sciences Biopharmaceuticals division. "This reliable, simple to use, and robust platform represents a significant time savings over traditional incubation sampling methods and can allow materials and final products to be released more quickly, improving production efficiency and reducing inventories."

Typical culture-based methods may need at least five days to produce results. Pall's GeneDisc System generates comparable results for most microbiological applications in just a few hours. The advantage provided by the GeneDisc System shortens the manufacturing cycle for pharmaceutical manufacturers, reducing warehousing costs, improving product time to market, and increasing ROI throughout the production process. The GeneDisc Rapid Microbiology System represents Pall's first step in providing a complete qPCR platform for rapid microbiology analysis.

The GeneDisc Rapid Microbiology System is efficient and easy to use. Its novel, highly simplified technology, based on bar-coded data input and fewer operator-dependent steps, ensures reliable results that significantly reduce the risk of user error. The economic design of the GeneDisc System also offers the unique advantage of moving assays to an operator with relatively modest training, freeing up technically skilled staff for more demanding duties.

This new application in Pall's GeneDisc product group is based on established quantitative polymerase chain reaction (qPCR) technology, which provides a simple, rapid tool for microbiological analysis. This single-protocol solution yields highly reproducible results with simplicity, speed and security, enabling quality control testing to be executed on a much shorter timetable than by using traditional methods.

The first of these assays is a Specified Microorganism Test, which simultaneously detects indicator pathogens as required by Pharmacopeia. Results are obtained within hours and not the several days required by traditional microbiology methods. Additional assays are planned that will further expand the GeneDisc System to perform accelerated microbiological testing during various stages of pharmaceutical and biotech production.

By improving internal quality assurance methods, Pall's GeneDisc System also adds an increased level of security to the pharmaceutical manufacturing process.

"Typical methods of sample analysis often require three to five days to detect contamination," says Dr. Peter Ball, Technical Marketing Director for Pall Life Sciences. "That can mean scrapped or reworked product, which represents considerable risk and cost. With the GeneDisc System, we can reliably eliminate those production risks in just a few hours," Ball says.

Amelia G. Tait-Kamradt, a Scientist at Pfizer, Inc., will present, "Using a Novel qPCR Platform to Accelerate Pharmaceutical Microbiology Testing," a whitepaper highlighting the advantages of the GeneDisc System at the Parenteral Drug Association's 5th Annual Global Conference on Pharmaceutical Microbiology, October 26, in Washington, D.C. For more information on the GeneDisc Rapid Microbiology System or any of the other Pall Corporation life sciences solutions, visit https://www.pall.co.uk/.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Pall Corporation. (2024, July 01). Pall launches GeneDisc Rapid Microbiology System for advanced microbial quality monitoring. News-Medical. Retrieved on October 07, 2024 from https://www.news-medical.net/news/20100917/Pall-launches-GeneDisc-Rapid-Microbiology-System-for-advanced-microbial-quality-monitoring.aspx.

  • MLA

    Pall Corporation. "Pall launches GeneDisc Rapid Microbiology System for advanced microbial quality monitoring". News-Medical. 07 October 2024. <https://www.news-medical.net/news/20100917/Pall-launches-GeneDisc-Rapid-Microbiology-System-for-advanced-microbial-quality-monitoring.aspx>.

  • Chicago

    Pall Corporation. "Pall launches GeneDisc Rapid Microbiology System for advanced microbial quality monitoring". News-Medical. https://www.news-medical.net/news/20100917/Pall-launches-GeneDisc-Rapid-Microbiology-System-for-advanced-microbial-quality-monitoring.aspx. (accessed October 07, 2024).

  • Harvard

    Pall Corporation. 2024. Pall launches GeneDisc Rapid Microbiology System for advanced microbial quality monitoring. News-Medical, viewed 07 October 2024, https://www.news-medical.net/news/20100917/Pall-launches-GeneDisc-Rapid-Microbiology-System-for-advanced-microbial-quality-monitoring.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pall launches new Acrodisc MS syringe filter